Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9505 - 9512 of 11454 results
The Supreme Court Continues to Punt on False Claims Cases
October 7, 2014| Blog| Viewpoint
California Raiders … Not the Football Kind
October 7, 2014| Blog| Viewpoint
He Loves Me, He Loves Me Not – Federal Appeals Court Confirms that Favoritism of a Paramour Is Not Gender Discrimination
October 7, 2014| Blog| Viewpoint
Taking 221(g) Administrative Processing Too Far?
October 6, 2014| Blog| Viewpoint
FDA Announces More Changes to FSMA Implementation Rules
October 6, 2014| Blog| Viewpoint
Tenth Circuit Affirms Class Certification and Price Fixing Verdict Against Dow Chemical
October 6, 2014| Advisory| Viewpoint
Federal Judge Rules to Allow Extrapolation on More Than 50,000 Patient Admissions in FCA Case
October 6, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.